市場調査レポート

商品コード

1423558

経皮毒性試験市場の2030年までの予測：タイプ別、試験法別、試験タイプ別、エンドユーザー別、地域別の世界分析

Dermal Toxicity Testing Market Forecasts to 2030 - Global Analysis By Type (Product, Services and Other Types), Testing Method (In-vitro Testing, In-silico Modeling and In-vivo testing), Test Type, End User and By Geography

出版日: 2024年02月02日 | 発行: Stratistics Market Research Consulting

| ページ情報: 英文 200+ Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,150 650,554円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 822,990円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 995,426円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,175,700円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、世界の経皮毒性試験市場は2023年に23億2,000万米ドルを占め、予測期間中のCAGRは10.3％で成長し、2030年には46億米ドルに達すると予測されています。

経皮毒性試験は、化学物質が皮膚に接触した際の潜在的な有害影響を評価するために採用される科学的手法です。このタイプの試験は、化粧品、医薬品、工業用化学物質など、さまざまな製品の安全性を評価するために極めて重要です。皮膚毒性試験では、皮膚の外観、紅斑（赤み）、浮腫（腫れ）、その他の刺激の兆候など、さまざまなパラメータが評価されます。

がん研究所によると、開発中の有効薬剤の数は90％以上増加し、2019年には3,876に達しました。現在、ヒトにおける薬剤の発がん性を評価するための長期げっ歯類がん原性試験が検討されています。

研究開発活動の増加

研究開発活動の増加は、革新的で安全な製品を市場に投入するための新製品や製剤の開発が極めて重要な役割を担っていることを裏付けています。これらの進歩の安全性プロファイルを評価するためには、包括的な経皮毒性試験が不可欠となります。さらに、進化する規制基準に適合させ、公衆衛生を守り、新しく開発された製品の安全性に対する消費者の信頼を植え付ける必要性により、経皮毒性試験サービスの需要が促進されています。

高コスト

経皮毒性試験には、正確で信頼性の高い結果を得るための専門的な施設や設備が必要です。そのような施設の維持、試験機器の取得と維持、熟練した人材の雇用にかかるコストは、莫大なものになる可能性があります。さらに、試験を必要とする物質が複雑で多様であることも、コストを押し上げる要因となっています。さらに、規制要件が進化するにつれて、追加試験や手法の更新が必要になる可能性があり、コンプライアンスにかかるコストの増加につながり、これが市場拡大の妨げとなっています。

消費者の意識の高まり

皮膚の健康と安全性に関する意識の高まりにより、消費者は製品ラベルを精査し、メーカーに透明性を求めるようになっています。消費者は、パーソナルケア製品、化粧品、医薬品に含まれる特定の化学物質への曝露に関連する潜在的リスクについて、より強く意識するようになっています。さらに、こうした安全性の重視は、健康と環境の持続可能性を優先した製品を求める消費者の広範な動向と一致しており、これがこの市場規模を押し上げています。

限られた標準化

標準化されたプロトコルやガイドラインがないため、正確なリスク評価を行ったり、異なる研究所や試験で得られた試験結果を解釈したりすることが課題となっていました。また、経皮暴露に関する物質の安全性を判断するための一貫した基準を確立することも困難でした。さらに、ハーモナイゼーションの欠如は、規制当局と業界関係者の双方にとって非効率とコスト増をもたらし、この市場拡大の妨げとなっています。

COVID-19の影響

COVID-19の流行は、経皮毒性試験市場にいくつかの悪影響を与えました。経皮毒性試験市場は製薬、化粧品、化学部門に大きく依存しており、パンデミックの間、これらすべてが混乱に見舞われました。研究所の閉鎖、施設へのアクセス制限、労働力の移動制限により、経皮毒性試験の円滑な実施が妨げられ、製品の承認やイントロダクションのスケジュールに影響を及ぼしました。さらに、景気後退により、一部の企業は必要不可欠でない試験サービスへの投資を再考するようになり、市場全体の成長に影響を与えました。

予測期間中、インシリコモデリング分野が最大になる見込み

インシリコモデリング分野は、分子間相互作用、吸収速度、皮膚への潜在的な悪影響をシミュレーションすることにより、経皮毒性の正確な予測を提供することを目的としているため、最大のシェアを占めると推定されます。これらのモデルは動物実験の削減に貢献し、倫理的配慮や試験手順における動物使用を最小限に抑える規制上の取り組みに合致しています。さらに、機械学習や人工知能などの技術の進歩は、インシリコモデルの精度と信頼性を向上させ、毒性評価における貴重なツールとなり、このセグメントの成長を促進しています。

皮膚腐食性試験分野は予測期間中に最も高いCAGRが見込まれる

皮膚腐食試験分野は、予測期間中にCAGRが最も高くなると予測されています。皮膚腐食性試験とは、化学熱傷につながる皮膚組織の破壊によって特徴付けられることが多い、皮膚への深刻な損傷を指します。これらの試験では通常、実験動物または試験管内モデルの皮膚に試験物質を塗布し、観察を行って皮膚損傷の程度を判定します。さらに、この結果は物質を腐食性か非腐食性かに分類するのに役立ち、製品の安全性評価に不可欠なデータを提供することで、規制上の決定や安全性評価の指針となります。

最大のシェアを占める地域

アジア太平洋地域は、産業の成長、規制状況の進展、製品の安全性に対する意識の高まりといった要因に影響されたダイナミックな市場情勢により、予測期間中に最大のシェアを占めました。この地域には、中国、日本、インド、韓国など多様な経済圏が含まれ、強固な毒性試験プロトコルを通じて製品の安全性確保に貢献しています。さらに、パーソナルケア製品や医薬品に関する消費者の意識の高まりが、この地域における包括的な経皮毒性試験の需要をさらに押し上げています。

CAGRが最も高い地域：

欧州は、消費者の安全性を重視し、試験管内モデルやインシリコモデルなどの代替手法への移行が顕著であることから、予測期間中にCAGRが最も高くなると予想されます。Charles River Laboratories International、MatTek Corporation、Intertek Group、GEヘルスケアなどの主要企業は、経皮毒性評価の精度と効率に貢献しています。さらに、米国環境保護庁（EPA）や食品医薬品局（FDA）のような機関によって設定された厳しい規制基準は、包括的な毒性試験の重要性を強調し、それによってこの地域を牽引しています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場プレイヤーの包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋地域
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東とアフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東とアフリカ

第10章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品の発売
事業拡大
その他の主要戦略

第11章企業プロファイル

SGS S.A
Bio-Rad Laboratories Inc.
Charles River Laboratories International, Inc.
Catalent, Inc.
Eurofins Scientific Inc
Thermo Fisher Scientific, Inc.
Covance, Inc
GE Healthcare
Qiagen N.V.
Merck KgaA
Intertek Group
MatTek Corporation
Evotec

図表

List of Tables

Table 1 Global Dermal Toxicity Testing Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Dermal Toxicity Testing Market Outlook, By Type (2021-2030) ($MN)
Table 3 Global Dermal Toxicity Testing Market Outlook, By Product (2021-2030) ($MN)
Table 4 Global Dermal Toxicity Testing Market Outlook, By Services (2021-2030) ($MN)
Table 5 Global Dermal Toxicity Testing Market Outlook, By Inhouse Services (2021-2030) ($MN)
Table 6 Global Dermal Toxicity Testing Market Outlook, By Outsource Services (2021-2030) ($MN)
Table 7 Global Dermal Toxicity Testing Market Outlook, By Other Types (2021-2030) ($MN)
Table 8 Global Dermal Toxicity Testing Market Outlook, By Testing Method (2021-2030) ($MN)
Table 9 Global Dermal Toxicity Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
Table 10 Global Dermal Toxicity Testing Market Outlook, By In-silico Modeling (2021-2030) ($MN)
Table 11 Global Dermal Toxicity Testing Market Outlook, By In-vivo testing (2021-2030) ($MN)
Table 12 Global Dermal Toxicity Testing Market Outlook, By Test Type (2021-2030) ($MN)
Table 13 Global Dermal Toxicity Testing Market Outlook, By Phototoxicity Tests (2021-2030) ($MN)
Table 14 Global Dermal Toxicity Testing Market Outlook, By Skin Irritation Tests (2021-2030) ($MN)
Table 15 Global Dermal Toxicity Testing Market Outlook, By Skin Sensitization Tests (2021-2030) ($MN)
Table 16 Global Dermal Toxicity Testing Market Outlook, By Skin Corrosion Tests (2021-2030) ($MN)
Table 17 Global Dermal Toxicity Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
Table 18 Global Dermal Toxicity Testing Market Outlook, By End User (2021-2030) ($MN)
Table 19 Global Dermal Toxicity Testing Market Outlook, By Cosmetics and Personal Care Products Industry (2021-2030) ($MN)
Table 20 Global Dermal Toxicity Testing Market Outlook, By Chemical Industry (2021-2030) ($MN)
Table 21 Global Dermal Toxicity Testing Market Outlook, By Healthcare Industry (2021-2030) ($MN)
Table 22 Global Dermal Toxicity Testing Market Outlook, By Other End Users (2021-2030) ($MN)
Table 23 North America Dermal Toxicity Testing Market Outlook, By Country (2021-2030) ($MN)
Table 24 North America Dermal Toxicity Testing Market Outlook, By Type (2021-2030) ($MN)
Table 25 North America Dermal Toxicity Testing Market Outlook, By Product (2021-2030) ($MN)
Table 26 North America Dermal Toxicity Testing Market Outlook, By Services (2021-2030) ($MN)
Table 27 North America Dermal Toxicity Testing Market Outlook, By Inhouse Services (2021-2030) ($MN)
Table 28 North America Dermal Toxicity Testing Market Outlook, By Outsource Services (2021-2030) ($MN)
Table 29 North America Dermal Toxicity Testing Market Outlook, By Other Types (2021-2030) ($MN)
Table 30 North America Dermal Toxicity Testing Market Outlook, By Testing Method (2021-2030) ($MN)
Table 31 North America Dermal Toxicity Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
Table 32 North America Dermal Toxicity Testing Market Outlook, By In-silico Modeling (2021-2030) ($MN)
Table 33 North America Dermal Toxicity Testing Market Outlook, By In-vivo testing (2021-2030) ($MN)
Table 34 North America Dermal Toxicity Testing Market Outlook, By Test Type (2021-2030) ($MN)
Table 35 North America Dermal Toxicity Testing Market Outlook, By Phototoxicity Tests (2021-2030) ($MN)
Table 36 North America Dermal Toxicity Testing Market Outlook, By Skin Irritation Tests (2021-2030) ($MN)
Table 37 North America Dermal Toxicity Testing Market Outlook, By Skin Sensitization Tests (2021-2030) ($MN)
Table 38 North America Dermal Toxicity Testing Market Outlook, By Skin Corrosion Tests (2021-2030) ($MN)
Table 39 North America Dermal Toxicity Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
Table 40 North America Dermal Toxicity Testing Market Outlook, By End User (2021-2030) ($MN)
Table 41 North America Dermal Toxicity Testing Market Outlook, By Cosmetics and Personal Care Products Industry (2021-2030) ($MN)
Table 42 North America Dermal Toxicity Testing Market Outlook, By Chemical Industry (2021-2030) ($MN)
Table 43 North America Dermal Toxicity Testing Market Outlook, By Healthcare Industry (2021-2030) ($MN)
Table 44 North America Dermal Toxicity Testing Market Outlook, By Other End Users (2021-2030) ($MN)
Table 45 Europe Dermal Toxicity Testing Market Outlook, By Country (2021-2030) ($MN)
Table 46 Europe Dermal Toxicity Testing Market Outlook, By Type (2021-2030) ($MN)
Table 47 Europe Dermal Toxicity Testing Market Outlook, By Product (2021-2030) ($MN)
Table 48 Europe Dermal Toxicity Testing Market Outlook, By Services (2021-2030) ($MN)
Table 49 Europe Dermal Toxicity Testing Market Outlook, By Inhouse Services (2021-2030) ($MN)
Table 50 Europe Dermal Toxicity Testing Market Outlook, By Outsource Services (2021-2030) ($MN)
Table 51 Europe Dermal Toxicity Testing Market Outlook, By Other Types (2021-2030) ($MN)
Table 52 Europe Dermal Toxicity Testing Market Outlook, By Testing Method (2021-2030) ($MN)
Table 53 Europe Dermal Toxicity Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
Table 54 Europe Dermal Toxicity Testing Market Outlook, By In-silico Modeling (2021-2030) ($MN)
Table 55 Europe Dermal Toxicity Testing Market Outlook, By In-vivo testing (2021-2030) ($MN)
Table 56 Europe Dermal Toxicity Testing Market Outlook, By Test Type (2021-2030) ($MN)
Table 57 Europe Dermal Toxicity Testing Market Outlook, By Phototoxicity Tests (2021-2030) ($MN)
Table 58 Europe Dermal Toxicity Testing Market Outlook, By Skin Irritation Tests (2021-2030) ($MN)
Table 59 Europe Dermal Toxicity Testing Market Outlook, By Skin Sensitization Tests (2021-2030) ($MN)
Table 60 Europe Dermal Toxicity Testing Market Outlook, By Skin Corrosion Tests (2021-2030) ($MN)
Table 61 Europe Dermal Toxicity Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
Table 62 Europe Dermal Toxicity Testing Market Outlook, By End User (2021-2030) ($MN)
Table 63 Europe Dermal Toxicity Testing Market Outlook, By Cosmetics and Personal Care Products Industry (2021-2030) ($MN)
Table 64 Europe Dermal Toxicity Testing Market Outlook, By Chemical Industry (2021-2030) ($MN)
Table 65 Europe Dermal Toxicity Testing Market Outlook, By Healthcare Industry (2021-2030) ($MN)
Table 66 Europe Dermal Toxicity Testing Market Outlook, By Other End Users (2021-2030) ($MN)
Table 67 Asia Pacific Dermal Toxicity Testing Market Outlook, By Country (2021-2030) ($MN)
Table 68 Asia Pacific Dermal Toxicity Testing Market Outlook, By Type (2021-2030) ($MN)
Table 69 Asia Pacific Dermal Toxicity Testing Market Outlook, By Product (2021-2030) ($MN)
Table 70 Asia Pacific Dermal Toxicity Testing Market Outlook, By Services (2021-2030) ($MN)
Table 71 Asia Pacific Dermal Toxicity Testing Market Outlook, By Inhouse Services (2021-2030) ($MN)
Table 72 Asia Pacific Dermal Toxicity Testing Market Outlook, By Outsource Services (2021-2030) ($MN)
Table 73 Asia Pacific Dermal Toxicity Testing Market Outlook, By Other Types (2021-2030) ($MN)
Table 74 Asia Pacific Dermal Toxicity Testing Market Outlook, By Testing Method (2021-2030) ($MN)
Table 75 Asia Pacific Dermal Toxicity Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
Table 76 Asia Pacific Dermal Toxicity Testing Market Outlook, By In-silico Modeling (2021-2030) ($MN)
Table 77 Asia Pacific Dermal Toxicity Testing Market Outlook, By In-vivo testing (2021-2030) ($MN)
Table 78 Asia Pacific Dermal Toxicity Testing Market Outlook, By Test Type (2021-2030) ($MN)
Table 79 Asia Pacific Dermal Toxicity Testing Market Outlook, By Phototoxicity Tests (2021-2030) ($MN)
Table 80 Asia Pacific Dermal Toxicity Testing Market Outlook, By Skin Irritation Tests (2021-2030) ($MN)
Table 81 Asia Pacific Dermal Toxicity Testing Market Outlook, By Skin Sensitization Tests (2021-2030) ($MN)
Table 82 Asia Pacific Dermal Toxicity Testing Market Outlook, By Skin Corrosion Tests (2021-2030) ($MN)
Table 83 Asia Pacific Dermal Toxicity Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
Table 84 Asia Pacific Dermal Toxicity Testing Market Outlook, By End User (2021-2030) ($MN)
Table 85 Asia Pacific Dermal Toxicity Testing Market Outlook, By Cosmetics and Personal Care Products Industry (2021-2030) ($MN)
Table 86 Asia Pacific Dermal Toxicity Testing Market Outlook, By Chemical Industry (2021-2030) ($MN)
Table 87 Asia Pacific Dermal Toxicity Testing Market Outlook, By Healthcare Industry (2021-2030) ($MN)
Table 88 Asia Pacific Dermal Toxicity Testing Market Outlook, By Other End Users (2021-2030) ($MN)
Table 89 South America Dermal Toxicity Testing Market Outlook, By Country (2021-2030) ($MN)
Table 90 South America Dermal Toxicity Testing Market Outlook, By Type (2021-2030) ($MN)
Table 91 South America Dermal Toxicity Testing Market Outlook, By Product (2021-2030) ($MN)
Table 92 South America Dermal Toxicity Testing Market Outlook, By Services (2021-2030) ($MN)
Table 93 South America Dermal Toxicity Testing Market Outlook, By Inhouse Services (2021-2030) ($MN)
Table 94 South America Dermal Toxicity Testing Market Outlook, By Outsource Services (2021-2030) ($MN)
Table 95 South America Dermal Toxicity Testing Market Outlook, By Other Types (2021-2030) ($MN)
Table 96 South America Dermal Toxicity Testing Market Outlook, By Testing Method (2021-2030) ($MN)
Table 97 South America Dermal Toxicity Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
Table 98 South America Dermal Toxicity Testing Market Outlook, By In-silico Modeling (2021-2030) ($MN)
Table 99 South America Dermal Toxicity Testing Market Outlook, By In-vivo testing (2021-2030) ($MN)
Table 100 South America Dermal Toxicity Testing Market Outlook, By Test Type (2021-2030) ($MN)
Table 101 South America Dermal Toxicity Testing Market Outlook, By Phototoxicity Tests (2021-2030) ($MN)
Table 102 South America Dermal Toxicity Testing Market Outlook, By Skin Irritation Tests (2021-2030) ($MN)
Table 103 South America Dermal Toxicity Testing Market Outlook, By Skin Sensitization Tests (2021-2030) ($MN)
Table 104 South America Dermal Toxicity Testing Market Outlook, By Skin Corrosion Tests (2021-2030) ($MN)
Table 105 South America Dermal Toxicity Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
Table 106 South America Dermal Toxicity Testing Market Outlook, By End User (2021-2030) ($MN)
Table 107 South America Dermal Toxicity Testing Market Outlook, By Cosmetics and Personal Care Products Industry (2021-2030) ($MN)
Table 108 South America Dermal Toxicity Testing Market Outlook, By Chemical Industry (2021-2030) ($MN)
Table 109 South America Dermal Toxicity Testing Market Outlook, By Healthcare Industry (2021-2030) ($MN)
Table 110 South America Dermal Toxicity Testing Market Outlook, By Other End Users (2021-2030) ($MN)
111 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Country (2021-2030) ($MN)
112 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Type (2021-2030) ($MN)
113 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Product (2021-2030) ($MN)
114 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Services (2021-2030) ($MN)
115 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Inhouse Services (2021-2030) ($MN)
116 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Outsource Services (2021-2030) ($MN)
117 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Other Types (2021-2030) ($MN)
118 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Testing Method (2021-2030) ($MN)
119 Middle East & Africa Dermal Toxicity Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
120 Middle East & Africa Dermal Toxicity Testing Market Outlook, By In-silico Modeling (2021-2030) ($MN)
121 Middle East & Africa Dermal Toxicity Testing Market Outlook, By In-vivo testing (2021-2030) ($MN)
122 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Test Type (2021-2030) ($MN)
123 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Phototoxicity Tests (2021-2030) ($MN)
124 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Skin Irritation Tests (2021-2030) ($MN)
125 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Skin Sensitization Tests (2021-2030) ($MN)
126 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Skin Corrosion Tests (2021-2030) ($MN)
127 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
128 Middle East & Africa Dermal Toxicity Testing Market Outlook, By End User (2021-2030) ($MN)
129 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Cosmetics and Personal Care Products Industry (2021-2030) ($MN)
130 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Chemical Industry (2021-2030) ($MN)
131 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Healthcare Industry (2021-2030) ($MN)
132 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Other End Users (2021-2030) ($MN)

Product Code: SMRC24792

According to Stratistics MRC, the Global Dermal Toxicity Testing Market is accounted for $2.32 billion in 2023 and is expected to reach $4.60 billion by 2030 growing at a CAGR of 10.3% during the forecast period. Dermal toxicity testing is a scientific method employed to assess the potential harmful effects of chemical substances when they come into contact with the skin. This type of testing is crucial for evaluating the safety of various products, including cosmetics, pharmaceuticals, and industrial chemicals. Various parameters are assessed during dermal toxicity testing, such as skin appearance, erythema (redness), edema (swelling), and other signs of irritation.

According to the Cancer Research Institute, the number of active drugs in development grew by more than 90%, to 3,876 in 2019. Long-term rodent carcinogenicity studies for assessing the carcinogenic potential of drugs in humans are currently being examined.

Market Dynamics:

Driver:

Increasing research and development activities

The growth in R&D activities underscores the pivotal role of the development of new products and formulations to introduce innovative and safe products to the market. Comprehensive dermal toxicity testing becomes imperative to assess the safety profile of these advancements. Further, by the need to align with evolving regulatory standards, safeguard public health, and instill consumer confidence in the safety of newly developed products, the demand for dermal toxicity testing services is propelled.

Restraint:

High cost

Dermal toxicity testing requires specialized facilities and equipment to ensure accurate and reliable results. The costs of maintaining such facilities, acquiring and maintaining testing equipment, and employing skilled personnel can be significant. The complexity and diversity of substances that require testing further contribute to the costs. Furthermore, as regulatory requirements evolve, additional tests or updated methodologies may be necessary, leading to increased costs for compliance, which is hampering this market expansion.

Opportunity:

Rising consumer awareness

Rising awareness regarding skin health and safety prompts consumers to scrutinize product labels and demand transparency from manufacturers. Consumers are becoming more conscious of the potential risks associated with exposure to certain chemicals present in personal care products, cosmetics, and pharmaceuticals. Additionally, this emphasis on safety aligns with the broader trend of consumers seeking products that prioritize health and environmental sustainability, which are driving this market size.

Threat:

Limited standardization

The absence of standardized protocols and guidelines made it challenging to make accurate risk assessments and interpret test results obtained from different laboratories or studies. It also made it difficult to establish consistent criteria for determining the safety of substances in relation to dermal exposure. Moreover, the lack of harmonization resulted in inefficiencies and increased costs for both regulators and industry stakeholders, which are hindering this market expansion.

Covid-19 Impact

The COVID-19 pandemic has had several negative impacts on the dermal toxicity testing market. The dermal toxicity testing market relies heavily on the pharmaceutical, cosmetic, and chemical sectors, all of which experienced disruptions during the pandemic. Laboratory closures, restricted access to facilities, and limitations on workforce mobility impeded the smooth conduct of dermal toxicity tests, affecting timelines for product approvals and introductions. Furthermore, the economic downturn has prompted some businesses to reconsider their investments in non-essential testing services, affecting overall market growth.

The in-silico modeling segment is expected to be the largest during the forecast period

The in-silico modeling segment is estimated to hold the largest share, due to they aim to provide accurate predictions of dermal toxicity by simulating molecular interactions, absorption rates, and potential adverse effects on the skin. These models contribute to the reduction of animal testing, aligning with ethical considerations and regulatory efforts to minimize animal use in testing procedures. In addition, advancements in technology, such as machine learning and artificial intelligence, enhance the accuracy and reliability of in-silico models, making them valuable tools in toxicology assessments which are driving this segment's growth.

The skin corrosion tests segment is expected to have the highest CAGR during the forecast period

The skin corrosion tests segment is anticipated to have highest CAGR during the forecast period. It refers to severe damage to the skin, often characterized by the destruction of skin tissue, leading to chemical burns. These tests typically involve the application of the test substance to the skin of experimental animals or in vitro models, and observations are made to determine the extent of skin damage. Furthermore, the results help classify substances as corrosive or non-corrosive, guiding regulatory decisions and safety assessments by providing essential data for product safety assessments, which is boosting this segment expansion.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to a dynamic landscape influenced by factors such as industrial growth, regulatory developments, and increasing awareness of product safety. The region encompasses diverse economies, including China, Japan, India, South Korea, and others, contributing to ensuring the safety of products through robust toxicity testing protocols. Moreover, increased awareness among consumers regarding personal care and pharmaceutical products further propels the demand for comprehensive dermal toxicity testing in this region.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to a strong focus on consumer safety and cutting-edge testing methodologies, with a notable shift towards alternative methods such as in vitro and in silico models. Key players such as Charles River Laboratories International, MatTek Corporation, Intertek Group, and GE Healthcare contribute to the accuracy and efficiency of dermal toxicity assessments. Further, stringent regulatory standards set by agencies like the U.S. Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA) emphasize the importance of comprehensive toxicity testing, thereby driving this region.

Key players in the market

Some of the key players in the Dermal Toxicity Testing Market include SGS S.A, Bio-Rad Laboratories Inc., Charles River Laboratories International, Inc., Catalent, Inc., Eurofins Scientific Inc, Thermo Fisher Scientific, Inc., Covance, Inc , GE Healthcare, Qiagen N.V., Merck KgaA, Intertek Group, MatTek Corporation and Evotec.

Key Developments:

In December 2023, GE HealthCare and Nantworks AirStrip announced an agreement to Commercialize Integrated Patient Monitoring and Cardiac Data Visualization for Healthcare Systems.

In December 2023, SGS is pleased to announce the signing of an agreement to divest its crop science operations in 14 countries to Eurofins Scientific.

In November 2023, GE HealthCare (Nasdaq: GEHC) and Masimo announced a joint agreement to integrate Masimo Signal Extraction Technology (SET) pulse oximetry into GE HealthCare's Portrait Mobile wireless and wearable patient monitoring solution.

In October 2023, SGS is pleased to have signed an agreement to divest its US powertrain testing operations as part of its strategic portfolio evolution to Columbia River Partners, a private equity firm focused on the industrials, business services and IT services sectors.

Types Covered:

Product
Services
Other Types

Testing Methods Covered:

In-vitro Testing
In-silico Modeling
In-vivo Testing

Test Types Covered:

Phototoxicity Tests
Skin Irritation Tests
Skin Sensitization Tests
Skin Corrosion Tests
Other Test Types

End Users Covered:

Cosmetics and Personal Care Products Industry
Chemical Industry
Healthcare Industry
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Dermal Toxicity Testing Market, By Type

5.1 Introduction
5.2 Product
5.3 Services
- 5.3.1 Inhouse Services
- 5.3.2 Outsource Services
5.4 Other Types

6 Global Dermal Toxicity Testing Market, By Testing Method

6.1 Introduction
6.2 In-vitro Testing
6.3 In-silico Modeling
6.4 In-vivo testing

7 Global Dermal Toxicity Testing Market, By Test Type

7.1 Introduction
7.2 Phototoxicity Tests
7.3 Skin Irritation Tests
7.4 Skin Sensitization Tests
7.5 Skin Corrosion Tests
7.6 Other Test Types

8 Global Dermal Toxicity Testing Market, By End User

8.1 Introduction
8.2 Cosmetics and Personal Care Products Industry
8.3 Chemical Industry
8.4 Healthcare Industry
8.5 Other End Users

9 Global Dermal Toxicity Testing Market, By Geography

9.1 Introduction
9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa

10 Key Developments

10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling

11.1 SGS S.A
11.2 Bio-Rad Laboratories Inc.
11.3 Charles River Laboratories International, Inc.
11.4 Catalent, Inc.
11.5 Eurofins Scientific Inc
11.6 Thermo Fisher Scientific, Inc.
11.7 Covance, Inc
11.8 GE Healthcare
11.9 Qiagen N.V.
11.10 Merck KgaA
11.11 Intertek Group
11.12 MatTek Corporation
11.13 Evotec

経皮毒性試験市場の2030年までの予測：タイプ別、試験法別、試験タイプ別、エンドユーザー別、地域別の世界分析

Dermal Toxicity Testing Market Forecasts to 2030 - Global Analysis By Type (Product, Services and Other Types), Testing Method (In-vitro Testing, In-silico Modeling and In-vivo testing), Test Type, End User and By Geography

最大のシェアを占める地域

CAGRが最も高い地域：

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

第4章 ポーターのファイブフォース分析

第5章 世界の経皮毒性試験市場：タイプ別

第6章 世界の経皮毒性試験市場：試験法別

第7章 世界の経皮毒性試験市場：試験タイプ別

第8章 世界の経皮毒性試験市場：エンドユーザー別

第9章 世界の経皮毒性試験市場：地域別

第10章 主な発展

第11章 企業プロファイル